All Dr Arun Upadhyay (Chief Scientific Officer and Head of Research & Development at Ocugen) articles
-
ArticleResetting retinal networks with a gene-agnostic approach
What if treating blindness did not mean fixing a single faulty gene? Find out how modifier gene therapy is designed to protect vision by targeting broader retinal pathways.